SFRP5 and metabolic dysfunction-associated steatohepatitis: Since SFRP5 binds with Wnt-5a, and Wnt-5a promotes the expression of proinflammatory cytokines by macrophages [27], we conclude that SFRP5 alleviates NASH by inhibiting Kupffer cell activation and intrahepatic inflammation.